FDA Grants Breakthrough Device Designation for neuroQUERTY software for Parkinson’s Disease Management Platform

The FDA has granted breakthrough device designation to nQ Medical’s neuroQUERTY software, which is designed to monitor brain health and Parkinson’s disease progression. Breakthrough device status is given to medical devices that have the potential to be an effective treatment or diagnostic tool for life-threatening or irreversibly debilitating diseases. 

Source link

Related posts

Inflammation in middle age may indicate increased risk of dementia in later life


A de novo variant in RAC3 causes severe global developmental delay and a middle interhemispheric variant of holoprosencephaly


I (Still) Want Adventure In The Great Wide Somewhere


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy